<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[bapineuzumab Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/bapineuzumab.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to bapineuzumab]]></description>
	<s:counts start="0" returned="2" found="2" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Elan Sees Problems on Alzheimer's Drug; Puts Itself Up for Sale]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000597/elan-sees-problems-on-alzheimers-drug-puts-itself-up-for-sale/]]></link>
		<description><![CDATA[Elan, the troubled Irish pharma company, has put itself up for sale just as it emerged that it will spend another six months testing bapineuzumab, its experimental Alzheimer's treatment. The drug has previously been linked to brain swelling in some patients. The sale raises the possibility that Elan's bizarre managers...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 14 Jan 2009 06:02:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/alzheimer%2527s+disease.html"><![CDATA[Alzheimer's Disease]]></category>
		<category domain="http://resources.bnet.com/topic/biogen+idec+inc..html"><![CDATA[Biogen Idec Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/elan.html"><![CDATA[Elan]]></category>
		<category domain="http://resources.bnet.com/topic/bapineuzumab.html"><![CDATA[Bapineuzumab]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BIIB</category>
		<category domain="tickers">BIIB</category>
	</item>
	<item>
		<title><![CDATA[Wyeth, Elan and Bapineuzumab -- How to Lie With (Drug) Statistics]]></title>
		<link><![CDATA[http://www.bnet.com/5208-14054-0.html?forumID=1&threadID=3367&messageID=16025&start=0]]></link>
		<description><![CDATA[Wyeth, Elan and Bapineuzumab -- How to Lie With Drug StatisticsRE: Wyeth, Elan and Bapineuzumab -- How to Lie With Drug StatisticsLook at page 15 at a dose of 0.15 mg/kg for APOE4 carriers and page 17 at a dose of 0.5 mg/kg for APOE4 noncarriers.http://library.corporate-ir.net/library/88/883/88326/items/302302/ELNWYE20080729.pdfThose a trualy amazing numbers.How...]]></description>
		<s:doctype><![CDATA[Discussion threads]]></s:doctype>
		<pubDate>Mon, 08 Sep 2008 17:52:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/bapineuzumab.html"><![CDATA[Bapineuzumab]]></category>
		<category domain="http://resources.bnet.com/topic/elan.html"><![CDATA[Elan]]></category>
		<category domain="http://resources.bnet.com/topic/wyeth.html"><![CDATA[Wyeth]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WYE</category>
		<category domain="tickers">WYE</category>
	</item>
</channel>
</rss>
